All News AlzeCure Pharma AB

Equities

ALZCUR

SE0010133785

Market Closed - Nasdaq Stockholm Other stock markets 08:53:08 27/06/2024 pm IST			5-day change	1st Jan Change
1.91 ^SEK	-0.26%		+1.87%	-38.59%

13/06	Alzecure Pharma AB Announces Positive Clinical Results with Painless ACD440 Against Neuropathic Pain	CI
14/05	AlzeCure Pharma AB Approves the Election of Jan Lundberg as New Ordinary Members of the Board of Directors	CI

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

AlzeCure decides on directed share issue to guarantor	14/06	AQ
New scientific article published on positive clinical results with Painless ACD440 against neuropathic pain	13/06	AQ
Alzecure Pharma AB Announces Positive Clinical Results with Painless ACD440 Against Neuropathic Pain	13/06	CI
AlzeCure Pharma AB - Eli Lilly's and AstraZeneca's former head of research Dr. Jan Lundberg elected as a new board member	16/05	AQ
Eli Lilly’s and AstraZeneca’s former head of research Dr. Jan Lundberg elected as a new board member	15/05	AQ
AlzeCure Pharma AB Approves the Election of Jan Lundberg as New Ordinary Members of the Board of Directors	14/05	CI
Communiqué from the annual general meeting of AlzeCure Pharma on 14 May 2024	14/05	AQ
AlzeCure reports anti-inflammatory effects with NeuroRestore ACD856 with relevance to Alzheimer's leading to new patent application	13/05	AQ
AlzeCure Pharma AB Reports Anti-Inflammatory Effects with NeuroRestore ACD856 with Relevance to Alzheimer's Leading to New Patent Application	13/05	CI
AlzeCure Pharma publishes prospectus	29/04	AQ
AlzeCure publishes its interim report for January – March 2024	25/04	AQ
AlzeCure Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04	CI
Eli Lilly's and AstraZeneca's former head of research Dr. Jan Lundberg invests in AlzeCure and is proposed for election to its board	10/04	AQ
Jan Lundberg acquired an unknown minority stake in AlzeCure Pharma AB (OM : ALZCUR).	10/04	CI
AlzeCure Pharma publishes its Annual Report for 2023	04/04	AQ
AlzeCure presents new data regarding the TrkA-NAM pain project at IASP 2024	03/04	AQ
AlzeCure Pharma AB Presents New Data Regarding the TrkA-NAM Pain Project at IASP 2024	03/04	CI
AlzeCure to partake in Redeye Theme, Alzheimer on March 21	15/03	AQ
AlzeCure to partake in Redeye Theme: Alzheimer on March 21	14/03	AQ
AlzeCure Presents New Preclinical Data with NeuroRestore ACD856 at Leading Alzheimer's Conference	07/03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News AlzeCure Pharma AB

Equities

ALZCUR

SE0010133785

All News

Filters